Techopia

Techopia Live: Noibu scaling at unprecedented rate

In this episode of Techopia Live, Noibu co-founder and CTO Filip Slatinac shares the company’s origin story, explains how Noibu is helping clients and teases what’s next.

Invert secures $25M in fresh capital to fund carbon-capture push

Ottawa startup says cash will go toward funding technology that reduces the amount of carbon in the atmosphere and developing its app that helps consumers track their own carbon footprints.

What’s in a name? Corel says rebranding to Alludo reflects venerable software firm’s evolution

The iconic name that still evokes smiles from many of its past employees is no longer front and centre as Ottawa-based company strives to reinvent itself decades after its heyday. 

Investment in Canadian fintech firms down more than 50% in first half of 2022: KPMG

The auditing firm says fintech companies in the country garnered US$810 million in investments across 85 deals in the first half of 2022, down from US$1.9 billion in the second half of 2021.

Shopify names Morgan Stanley executive as new chief financial officer

Shopify founder and chief executive Tobi Lutke says the company will benefit from Hoffmeister's more than 20 years of investment banking experience in the technology sector.

Curating the perfect business meeting in Kingston

Ted Robinson isn’t originally from Kingston, and that, he says, allows him to see the city from...

Leonovus has ‘no clear path to revenue,’ software firm says in Q2 financial filings

Ottawa company said it brought in revenues of $5,000 in the three-month period ending June 30, compared with zero sales a year earlier. 

‘Well set up to win’: Lytica raises $13M as it chases global customers for pricing intelligence software

Kanata firm’s artificial intelligence platform compares prices of thousands of components that go into electronic devices such as computers and smartphones.

Tetra Bio-Pharma hopes $6M raise carries firm through to revenue stage

Orl​éans-based company has spent years developing drugs designed to mimic the pain-killing and anti-inflammatory benefits of cannabis without major side effects.

Mayo Clinic acquires equity stake in rapid COVID test-maker Genomadix

Ottawa startup awaiting regulatory approval for portable device says partnership with world-renowned U.S. research facility will help further develop its technology.

OBJ360 Sponsored

Guest Blogs

Social Galleries

Video

Event Calendar